Related Experiment Video

Updated: Oct 23, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.5K

Lower LDL-cholesterol levels associated with increased inflammatory burden in patients with acute ST-segment

Eser Açıkgöz1, Sadık Kadri Açıkgöz2, Belma Yaman3

  • 1Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Department of Cardiology - Ankara, Turkey.

Revista Da Associacao Medica Brasileira (1992)
|August 18, 2021
PubMed

Insights

Lowering low-density lipoprotein cholesterol (LDL-C) in ST-elevation myocardial infarction (STEMI) patients is linked to increased inflammation. This study found higher hs-CRP levels with lower LDL-C, suggesting a complex relationship in acute cardiac events.

Area of Science:

  • Cardiology
  • Biochemistry
  • Inflammation Research

Background:

  • ST-elevation myocardial infarction (STEMI) is a critical cardiovascular event.
  • Low-density lipoprotein cholesterol (LDL-C) is a known risk factor for cardiovascular disease.
  • Highly sensitive C-reactive protein (hs-CRP) is a marker of inflammation.

Purpose of the Study:

  • To assess the association between LDL-C levels and hs-CRP in patients diagnosed with STEMI.
  • To investigate the correlation between LDL-C and hs-CRP in an acute myocardial infarction cohort.

Main Methods:

  • 591 STEMI patients were stratified into tertiles based on serum LDL-C levels.
  • Differences in hs-CRP levels were compared across LDL-C tertiles.
  • Correlations between hs-CRP and lipid profiles (LDL-C, total cholesterol, HDL-C) were analyzed.

Main Results:

  • Significant differences in hs-CRP levels were observed across LDL-C tertiles (p<0.001).
  • The highest hs-CRP levels were found in the lowest LDL-C tertile, and the lowest hs-CRP in the highest LDL-C tertile.
  • A significant negative correlation was found between hs-CRP and LDL-C (r=-0.332, p<0.001), and total cholesterol (r=-0.326, p<0.001).

Conclusions:

  • Lower LDL-C levels in STEMI patients are associated with a higher inflammatory burden.
  • The findings suggest a complex interplay between lipid metabolism and inflammation in acute myocardial infarction.
  • Further research is needed to understand the clinical implications of these associations in STEMI.
Abstract

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.4K
Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.3K

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
91
Inflammation01:38

Inflammation

Overview
56.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
75
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
49
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
154
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
101